Ron Zwanziger

Ron Zwanziger (; born 1954) is an Israeli-American businessman. He is best known for founding and leading the diagnostic test manufacturer Alere.

Early life and education Zwanziger was born in Israel in 1954 and raised on the island of Cyprus after 1956.

He earned an engineering degree from Imperial College London in 1975 and an MBA from Harvard Business School in 1981. This technology required less blood to obtain a reading, and by 2008 was used in a majority of the 6 billion home blood glucose tests being performed annually.

Medisense was acquired by Abbott Laboratories in 1996 for $876 million.

Alere (1991-2014) Zwanziger founded Alere Inc. (then called Selfcare Inc.),

Alere's diabetes unit was sold to Johnson and Johnson (LifeScan) in 2001 for $1.3 billion. By 2012, Alere was the largest manufacturer in the HIV testing space, according to the nonprofit Population Services International.

Abbott Laboratories acquired Alere in 2017 for $5.3 billion.

LumiraDx (2014-2023) Along with longtime partners He was CEO until November 2023, when all three founders resigned amid "financial difficulties" at the company. On December 29, 2023, LumiraDx reached a $350 million agreement to sell its key assets to Roche Diagnostics.

LumiraDx produces several rapid diagnostic tests which are read by a single brick-sized device at the point of care. A 2021 presentation by Bill Gates hailed the LumiraDx platform as "amazing" and "cheaper and smaller than the diagnostic devices that came before." A 2021 meta-analysis of 133 studies showed that LumiraDx's COVID-19 rapid antigen test had the highest sensitivity among 61 products.